Literature DB >> 7862453

The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells.

M A den Bakker1, P H Riegman, R A Hekman, W Boersma, P J Janssen, T H van der Kwast, E C Zwarthoff.   

Abstract

Neurofibromatosis type 2 (NF2) is a disease resulting in the formation of schwannomas of the eighth cranial nerve, and other central nervous system tumours. A tumour suppressor gene has been found to be responsible for this disorder. The 595 amino acid NF2 protein shows a great deal of homology to a superfamily of membrane organizing proteins. To generate antibodies against the NF2 protein four synthetic peptides (SP) were injected in rabbits. COS cells transfected with an NF2 cDNA construct in an expression vector were used for immunocytochemical staining experiments; lysates of transfected COS cells were used for Western blotting experiments, as were lysates of E. coli cultures transformed with an NF2 cDNA construct subcloned in a prokaryotic expression vector. In western blots all sera detected a band indicating the appropriate molecular weight in lysates of transfected COS cells and E. coli. Immunocytochemical staining experiments indicate that the NF2 protein localizes in or near the cell membrane. Immunohistochemical staining of human tissue sections demonstrated the presence of the NF2 protein in muscle-, and Schwann cells. These results support the hypothesis that the NF2 protein functions as a membrane organizing element.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862453

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Three determinants in ezrin are responsible for cell extension activity.

Authors:  M Martin; C Roy; P Montcourrier; A Sahuquet; P Mangeat
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

2.  The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.

Authors:  M F James; N Manchanda; C Gonzalez-Agosti; J H Hartwig; V Ramesh
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

3.  Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.

Authors:  R P Stokowski; D R Cox
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

4.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.

Authors:  Banumathi K Cole; Marcello Curto; Annie W Chan; Andrea I McClatchey
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

6.  Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.

Authors:  M A den Bakker; M Tascilar; P H Riegman; A C Hekman; W Boersma; P J Janssen; T A de Jong; W Hendriks; T H van der Kwast; E C Zwarthoff
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

7.  Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.

Authors:  Minja Laulajainen; Maria Melikova; Taru Muranen; Olli Carpén; Mikaela Grönholm
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.